News
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
11 Apr 24
Long Ideas, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade
4 Apr 24
Cryptocurrency, Equities, News, Markets, ETFs
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
4 Apr 24
News, Penny Stocks, Small Cap, Markets, Trading Ideas
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
3 Apr 24
Cryptocurrency, News, ETFs
Stifel Maintains Buy on Verve Therapeutics, Lowers Price Target to $40
3 Apr 24
News, Price Target, Analyst Ratings
Nasdaq Down Over 1%; VivoPower International Shares Spike Higher
2 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
2 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
2 Apr 24
Movers
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
2 Apr 24
Biotech, News, Health Care, Movers, General
Crude Oil Surges Over 1%; US Factory Orders Increase In February
2 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
2 Apr 24
Movers
Verve Therapeutics Announces Updates On PCSK9 Program, Company To Pause Enrollment In Heart-1 Clinical Trial Following Asymptomatic Grade 3 Transient Alt Elevation And Thrombocytopenia Seen In Sixth Participant Enrolled In 0.45 Mg/Kg Dose Cohort
2 Apr 24
News
RBC Capital Reiterates Outperform on Verve Therapeutics, Maintains $35 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Verve Therapeutics: Q4 Earnings Insights
27 Feb 24
Earnings
Verve Therapeutics Q4 GAAP EPS $(0.69) Beats $(0.82) Estimate, Sales $5.14M Beat $1.17M Estimate; Cash, Cash Equivalents and Marketable Securities of $624M With Cash Runway into Late 2026
27 Feb 24
Earnings, News
Press releases
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws
19 Apr 24
Press Releases
Attention Verve Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
2 Apr 24
News, Legal, Press Releases
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
2 Apr 24
News, Legal, Press Releases
Verve Therapeutics Announces Updates on its PCSK9 Program
2 Apr 24
Press Releases
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
1 Mar 24
Press Releases
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
Earnings, Press Releases
Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
1 Feb 24
News, Press Releases